Medical Oncology

Papers
(The TQCC of Medical Oncology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Cancer induced bone pain: current management and future perspectives43
Cancer stem cell characteristics and their potential as therapeutic targets42
Vaccination of cancer patients against COVID-19: towards the end of a dilemma41
Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells32
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer27
Correction to: The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma26
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma25
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies22
Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway22
Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation21
Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools20
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs19
Computational study on novel natural inhibitors targeting BCL219
Identification of key genes in the tumor microenvironment of lung adenocarcinoma19
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.18
Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity17
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance17
Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor16
Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia16
Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group15
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter 15
Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine15
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis15
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?15
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model13
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer13
Correction to: Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes13
In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells13
The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma13
A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways13
Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis13
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors13
CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction12
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies12
Lipid droplet evolution gives insight into polyaneuploid cancer cell lipid droplet functions12
PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer12
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients12
How should we manage non-small-cell lung cancer “not-otherwise-specified”?11
Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer11
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radio11
Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissues11
Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway11
Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?11
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer11
Forward to a methodological proposal to support cancer patients: the dialogics’ contribution for the precision care11
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer11
Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy11
0.047611951828003